Extended-release pain medicine for older adults with cancer and kidney issues
Part of Kidney & urinary, Pain, Women’s health & pregnancy clinical trials.
This study tests an extended-release pain medicine (hydromorphone) for older adults with cancer pain and mild kidney problems. It aims to see if this medicine is safe and helpful for people whose kidneys aren't working perfectly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years of age or older.
- You have cancer that has been confirmed by a biopsy or similar test.
- You have moderate to severe cancer pain (score of 4 or more on a 0-10 pain scale) and have not yet taken strong opioid pain relievers.
- Your kidneys are working at a normal or mildly reduced level (your doctor can confirm this with a blood test).
- You are expected to live at least 3 more months and are able to take medicines by mouth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding electroacupuncture (a treatment using mild electric pulses on needles) and ear acupressure (pressing on specific points on the ear) to the pain medicine hydromorphone helps reduce cancer-related pain that isn't well managed by usual treatments.
This trial tests whether adding non-opioid pain relievers (like dipyrone or ibuprofen) to your usual opioid pain medication can better control cancer pain. It aims to see if the combination is more effective and safe.
This study tests whether a new pain medication called 3D1002, when combined with a long-acting opioid, can better manage moderate to severe cancer pain compared to the opioid alone. The goal is to find a more effective way to reduce pain without increasing side effects.
This trial tests a quick-acting pain medicine (hydromorphone) given through a vein to treat severe chest pain. It may be an option for people experiencing acute pain who haven't been helped by other medicines.
This trial compares two different pain medicines (methadone given by mouth or IV vs. hydromorphone given through a spinal injection) after surgery for gynecologic cancer. It aims to find which option provides better pain relief with fewer side effects.
This study tests a pain medicine called hydromorphone to see how well it controls pain in ICU patients on breathing machines. The goal is to make patients more comfortable while they are recovering.
Hear when a new Cancer Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.